On the occasion of National Girl Child Day and Cervical Cancer Awareness month, the Serum Institute of India's CEO Adar Poonawalla and Home Minister Amit Shah launched CERVAVAC, a cervical cancer vaccine. CERVAVAC is India's first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine. It has shown a strong antibody response against all targeted HPV types across all age groups.